Viatris price target lowered to $9 from $12 at Barclays
PremiumThe FlyViatris price target lowered to $9 from $12 at Barclays
1M ago
Viatris Reports Strong 2024 Financial Results
Premium
Company Announcements
Viatris Reports Strong 2024 Financial Results
1M ago
Viatris, Inc. Earnings Call: Balancing Growth and Challenges
Premium
Company Announcements
Viatris, Inc. Earnings Call: Balancing Growth and Challenges
1M ago
Viatris confirms receipt of warning letter, import alert for India facility
PremiumThe FlyViatris confirms receipt of warning letter, import alert for India facility
3M ago
Viatris announces publication of CARE study results
Premium
The Fly
Viatris announces publication of CARE study results
4M ago
Viatris Elects Directors and Amends Stock Plan at Meeting
Premium
Company Announcements
Viatris Elects Directors and Amends Stock Plan at Meeting
4M ago
VTRS Earnings this Week: How Will it Perform?
PremiumPre-EarningsVTRS Earnings this Week: How Will it Perform?
5M ago
Lexicon signs licensing agreement with Viatris for sotagliflozin
Premium
The Fly
Lexicon signs licensing agreement with Viatris for sotagliflozin
6M ago
Lexicon receives $25M upfront from Viatris for exclusive sotagliflozin license
Premium
The Fly
Lexicon receives $25M upfront from Viatris for exclusive sotagliflozin license
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100